1. Home
  2. Tags
  3. Drug Development Incentives

Latest Drug Development Incentives News

Page 1 of 1
US Congress Extends Rare Pediatric Disease Voucher Program to 2029, Boosting Neuren’s Prospects

US Congress Extends Rare Pediatric Disease Voucher Program to 2029, Boosting Neuren’s Prospects

The US Congress has reauthorized the Rare Pediatric Disease Priority Review Voucher program through September 2029, a move that could significantly benefit Neuren Pharmaceuticals as it advances its rare disease drug candidates.
Ada Torres
Ada Torres
5 Feb 2026